NCT04178109

Brief Summary

Pain is a global public health issue and represents the most common reason for both physician consultation and hospital admissions . When unrelieved or poorly controlled, it is associated with medical complications, poor patient satisfaction and increased risk of developing chronic pain. Dexketoprofen is a new NSAID treating acute postoperative pain and when it combined with tramadol may have a better effect. The purpose of this study is to evaluate the analgesic effect of the oral use of the combination of dexketoprofen/tramadole on the reduction of postoperative pain after total hip arthroplasty with minimal invasive anterior approach (AMIS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
226

participants targeted

Target at P75+ for phase_2 postoperative-pain

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2019

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2019

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 24, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 26, 2019

Completed
Last Updated

November 26, 2019

Status Verified

November 1, 2019

Enrollment Period

10 months

First QC Date

November 24, 2019

Last Update Submit

November 24, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • Pain score in 8hours

    Pain score with the visualised analogue scale in 8hours

    8 hours

  • Pain score in 24hours

    Pain score with the visualised analogue scale in 24 hours

    24 hours

  • Pain score in 48 hours

    Pain score with the visualised analogue scale in 48 hours

    48 hours

  • Pain score in 72 hours

    Pain score with the visualised analogue scale in 72 hours

    72 hours

  • Total analgesic consumption

    Total analgesic consumption as rescue analgesia the first 24 hours

    24 houra

Secondary Outcomes (1)

  • Side effects

    72 hours

Study Arms (2)

Group A

ACTIVE COMPARATOR

Group A was under spinal anesthesia with a 25G cutting edge needle with levobupivacaine 10-15mg and fentanyl 10μg. Periarticular injection was done by the surgeon with a dilition of 100ml N/S 0,9% with 300mg ropivacaine and 0,5mg epinephrine. Group A was given the oral combination dexketoprofen/tramadole (25mg/75mg) 2h after surgery every 8h for 72h.

Drug: Dexketoprofen/tramadol (27mg/75mg)Drug: Ropivacaine Hydrochloride 7.5 MG/MLDrug: Levobupivacaine Hydrochloride

Group B

PLACEBO COMPARATOR

Group B was under spinal anesthesia with a 25G cutting edge needle with levobupivacaine 10-15mg and fentanyl 10μg. Periarticular injection was done by the surgeon with a dilition of 100ml N/S 0,9% with 300mg ropivacaine and 0,5mg epinephrine. Group B received postoperative analgesia with intravenous tramadole 75mg and paracetamol 1g every 8h with the first dose beginning 2h after the end of the surgery. For 72h

Drug: Tramadol hydrochlorideDrug: ParacetamolDrug: Ropivacaine Hydrochloride 7.5 MG/MLDrug: Levobupivacaine Hydrochloride

Interventions

Postoperatively patients in Group A received the oral combination dexketoprofen/tramadol for the treatment of acute postoperative pain the first 72h

Group A

Patients in group B received IV tramadol 75mg every 8h

Group B

Patients in group B received IV paracetamol 1g every 8h

Group B

300mg ropivacaine as periarticular injection in a dilution of 100ml n/s 0,9% was done by the orthopedic surgeon in all patients

Group AGroup B

10-15mg levobupivacaine was done subarachnoidal for spinal anesthesia

Group AGroup B

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral total hip arthroplasty with a direct anterior minimal invasive technique
  • ASA score I or II
  • signed written informed consent form
  • days hospitalization
  • years old
  • primary Total hip arthroplasty

You may not qualify if:

  • allergy to any given drugs
  • contraindications for spinal anesthesia
  • active bleeding
  • renal failure ( gfr\< 90ml/h)
  • hepatic failure ( abnormal sgot,sgpt,γgt)
  • heart failure
  • history of gastrointestinal bleeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elena Nikolakopoulou

Athens, Kifissia, 14571, Greece

Location

Related Publications (1)

  • Macheras GA, Tzefronis D, Argyrou C, Nikolakopoulou E, Galvez Miravete A, Karachalios TS. Pain management after total hip arthroplasty: comparative study of analgesic efficacy and tolerability between oral tramadol/dexketoprofen and injectable paracetamol + tramadol. Hip Int. 2024 May;34(3):304-310. doi: 10.1177/11207000231219797. Epub 2024 Jan 10.

MeSH Terms

Conditions

Pain, PostoperativeAcute Pain

Interventions

dexketoprofen trometamolTramadolAcetaminophenRopivacaineLevobupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanolsHexanolsFatty AlcoholsAlcoholsOrganic ChemicalsDimethylaminesMethylaminesAminesLipidsAcetanilidesAnilidesAmidesAniline CompoundsBupivacaine

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 24, 2019

First Posted

November 26, 2019

Study Start

January 10, 2019

Primary Completion

November 10, 2019

Study Completion

November 20, 2019

Last Updated

November 26, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will share

Locations